AstraZeneca PLC (BCBA:AZN)

Argentina flag Argentina · Delayed Price · Currency is ARS
68,200
-450 (-0.66%)
At close: Dec 4, 2025
84.82%
Market Cap 405.22T
Revenue (ttm) 79.66T
Net Income (ttm) 12.88T
Shares Out n/a
EPS (ttm) 8,248.60
PE Ratio 31.46
Forward PE 17.93
Dividend 795.69 (1.16%)
Ex-Dividend Date Aug 8, 2025
Volume 214
Average Volume 268
Open 68,200
Previous Close 68,650
Day's Range 68,100 - 68,500
52-Week Range 35,700 - 79,800
Beta n/a
RSI 52.75
Earnings Date Feb 10, 2026

About AstraZeneca

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Crestor, Seloken, Lokelma, Roxadustat, Andexxa, Wainua, Symbicort, Fasenra, Pulmicort, Breztri/Trixeo, Saphnelo, Tezspire, Airsupra, Ultomiris, Soliris, Strensiq, Koselugo, Kanuma, Atacand, Plendil, Modip, Splendil, Munobal, Flodil, Komboglyze, Qtern, B... [Read more]

Industry Pharmaceutical Preparations
Founded 1992
Employees 94,300
Stock Exchange Buenos Aires Stock Exchange
Ticker Symbol AZN
Full Company Profile

Financial Performance

In 2024, AstraZeneca's revenue was $54.07 billion, an increase of 18.03% compared to the previous year's $45.81 billion. Earnings were $7.04 billion, an increase of 18.14%.

Financial numbers in USD Financial Statements

News

There is no news available yet.